What we learned about the role of antenatal magnesium sulfate for the prevention of cerebral palsy

Semin Perinatol. 2016 Aug;40(5):303-6. doi: 10.1053/j.semperi.2016.03.007. Epub 2016 Apr 23.

Abstract

Based on the convincing case control study of Nelson and Grether which suggested that the administration of magnesium sulfate to mothers prior to early preterm birth might protect their offspring from cerebral palsy, and a pilot study by John Hauth et al. at the University of Alabama at Birmingham, the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network, with co-funding from the National Institute of Neurologic Disorders and Stroke embarked on the Beneficial Effects of Antenatal Magnesium (BEAM) Trial in 1997.

Keywords: Cerebral palsy; Magnesium sulfate.

Publication types

  • Review

MeSH terms

  • Adult
  • Case-Control Studies
  • Cerebral Palsy / drug therapy
  • Cerebral Palsy / prevention & control*
  • Double-Blind Method
  • Evidence-Based Medicine
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Premature, Diseases / drug therapy
  • Infant, Premature, Diseases / physiopathology
  • Infant, Premature, Diseases / prevention & control*
  • Magnesium Sulfate / therapeutic use*
  • Neuroprotective Agents / therapeutic use*
  • Pilot Projects
  • Pregnancy
  • Premature Birth / physiopathology
  • Prenatal Care* / methods
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • Neuroprotective Agents
  • Magnesium Sulfate